Ken Griffin Organovo Holdings, Inc. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.43 - $0.76 $774 - $1,368	-1,800 Reduced 9.57%	17,000 $8,000
Q2 2024 Aug 14, 2024	BUY	$0.75 - $1.35 $1,950 - $3,510	2,600 Added 16.05%	18,800 $14,000
Q1 2024 May 15, 2024	BUY	$0.9 - $1.17 $14,580 - $18,954	16,200 New	16,200 $16,000
Q2 2023 Aug 14, 2023	SELL	$1.64 - $2.24 $8,364 - $11,424	-5,100 Reduced 39.84%	7,700 $13,000
Q1 2023 May 15, 2023	BUY	$1.44 - $3.2 $18,432 - $40,960	12,800 New	12,800 $28,000

2.44M

17K

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $2.96M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.